Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective

Hypertension in Pregnancy

Volumn 32, Issue 2, 2013, Pages 105-119

  Hadker, Nandini ^a   Garg, Suchita ^a   Costanzo, Cory ^a   Van Der Helm, Wim ^b   Creeden, James ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b Roche Diagnostics Ltd   (Switzerland)

Author keywords

Costs; Diagnosis; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA METHYLDOPAMINE; DIHYDRALAZINE; MAGNESIUM SULFATE; NIFEDIPINE;

AMBULATORY CARE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BUDGET; CARDIOTOCOGRAPHY; CLINICAL PRACTICE; COST CONTROL; DELIVERY; DIAGNOSTIC TEST; DOPPLER FLOWMETRY; ECLAMPSIA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GERMANY; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; INCIDENCE; LENGTH OF STAY; MATERNAL MORTALITY; OBSTETRIC PROCEDURE; PATIENT CARE; PATIENT CODING; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PROTEINURIA; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; URIC ACID BLOOD LEVEL; URINALYSIS;

DECISION SUPPORT TECHNIQUES; FALSE POSITIVE REACTIONS; FEMALE; GERMANY; HUMANS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL CARE;

EID: 84878579116     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2011.638958     Document Type: Article

References (29)

1. Stella CL, Sibai BM. Preeclampsia: diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med 2006;19:381-6. (Pubitemid 44272911)
2. Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004;70:2317-24. (Pubitemid 39657180)
3. Bhattacharya S, Campbell DM. The incidence of severe complications of preeclampsia. Hypertens Pregnancy 2005;24:181-90. (Pubitemid 40911355)
4. Statistisches Bundesamt (German Federal Statistical Office). Population movement: births and deaths; 2008. Available online at: http://www.destatis.de/ jetspeed/portal/cms/Sites/destatis/Internet/EN/Content/Statistics/Bevoelkerung/ Geburten Sterbefaelle/Tabellen/Content75/BirthDeaths, templateId=renderPrint. psml [last accessed August 2009].
5. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft Schwangerschaftshochdruck/Gestose. AWMF. 2010. 015/018. Available online at: http://www.awmf.org/uploads/tx-szleitlinien/015-018-S1- Diagnostik-und-Therapie-hypertensiver-Schwangerschaftserkrankungen-05-2008-12- 2011.pdf (accessed April 10, 2013).
6. Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005;330:576-80. (Pubitemid 40380353)
7. Cnossen JS, ter Riet G, Mol BW, et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand 2009;88:758-65.
8. Meads CA, Cnossen JS, Meher S, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008;12:iii-iv, 1-270.
9. Buhimschi CS, Norwitz ER, Funai E, et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005;192:734-41. (Pubitemid 40311263)
10. Muy-Rivera M, Vadachkoria S, Woelk GB, et al. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women. Physiol Res 2005;54:611-22. (Pubitemid 43161727)
11. Woolcock J, Hennessy A, Xu B, et al. Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust N Z J Obstet Gynaecol 2008;48:64-70. (Pubitemid 351239132)
12. Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 2006;195:255-9. (Pubitemid 43927517)
13. Lee ES, Oh MJ, Jung JW, et al. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci 2007;22:94-8.
14. Kim YJ, Park H, Lee HY, et al. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007;133:47-52. (Pubitemid 46962877)
15. Teixeira PG, Cabral AC, Andrade SP, et al. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Pregnancy 2008;27:65-73. (Pubitemid 351302216)
16. Noori M, Donald AE, Angelakopoulou A, et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010;122:478-87.
17. Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161e161-161e111.
18. Hadker N, Garg S, Costanzo C, et al. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective. J Med Econ 2010;13:728-37.
19. Gebührenordnung für Arzte (GOA) mit verkürzten Leistungsbezeichnungen (Fees for Doctors); 2008. Available online at: http://www.pkv.de/recht/rechtsquellen/gebuehrenordnung-fuer-aerzte-goae.pdf (accessed April 10, 2013).
20. National Online Pharmacy. Available online at: http://www.shop-apotheke. com/[last accessed July 2009].
21. Ausgaben der Krankenhäuser pro Pflegetag (Hospital Expenditures per Treatment Day) Published in Bundeszentrale für politische Bildung (BPD). Available online at: http://www.bpb.de/files/5L6A6B.pdf [last accessed July 2009].
22. Statistisches Bundesamt (German Federal Statistical Office). Price and volume measures for hospital services in national accounts; 2008. Available online at: http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/ EN/Content/Publikationen/SpecializedPublications/Nationalaccounts/ Pricehospitalservices, property=file.pdf [last accessed July 2009].
23. Institut für das Entgeltsystem im Krankenhaus (InEK GmbH) (Institute for the Hospital Remuneration System). G-DRG-Fallpauschalen-Katalog 2009 nebst Anlagen (DRG Catalog 2009). Available online at: http://www.g-drg.de/cms/ (accessed April 10, 2013).
24. Lapaire O, Shennan A, Stepan H. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol 2010;151:122-9.
25. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83. (Pubitemid 38364626)
26. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
27. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008;156:918-30.
28. Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16:206-215. (Pubitemid 40314413)
29. Sibai BM. Caring for women with hypertension in pregnancy. JAMA 2007;298: 1566-8. (Pubitemid 47529392)